nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-2771768D·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.2 Clinical medicine·Subfield: Obstetrics and Gynecology·Basis: Full text·Type: Cross-sectional study

Preeclampsia Affects Lipid Metabolism and HDL Function in Mothers and Their Offspring.

Stadler et al.Stadler, Scharnagl, Wadsack et al.·2023·Antioxidants (Basel, Switzerland)·10.3390/antiox12040795 ↗

Primary claim

early-onset, as well as late-onset, PE affect maternal and neonatal lipid metabolism, potentially contributing to disease manifestation and increased cardiovascular risk later in life

Tentative · delivery-time observational measurements cannot establish causal effects or later cardiovascular consequences
In brief

Paired maternal and cord-blood profiling extends preeclampsia lipid research, but the delivery-time observational design cannot establish the causal effects claimed.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

Preeclampsia (PE) is linked to an overall increased cardiovascular risk for both the mother and child. Functional impairment of high-density lipoproteins (HDL) may contribute to the excess cardiovascular risk associated with PE. In this study, we investigated the effects of PE on maternal and neonatal lipid metabolism, and the parameters of HDL composition and function. The study cohort included 32 normotensive pregnant women, 18 women diagnosed with early-onset PE, and 14 women with late-onset PE. In mothers, early- and late-onset PE was associated with atherogenic dyslipidemia, characterized by high plasma triglycerides and low HDL-cholesterol levels. We observed a shift from large HDL to smaller HDL subclasses in early-onset PE, which was associated with an increased plasma antioxidant capacity in mothers. PE was further associated with markedly increased levels of HDL-associated apolipoprotein (apo) C-II in mothers, and linked to the triglyceride content of HDL. In neonates of early-onset PE, total cholesterol levels were increased, whereas HDL cholesterol efflux capacity was markedly reduced in neonates from late-onset PE. In conclusion, early- and late-onset PE profoundly affect maternal lipid metabolism, potentially contributing to disease manifestation and increased cardiovascular risk later in life. PE is also associated with changes in neonatal HDL composition and function, demonstrating that complications of pregnancy affect neonatal lipoprotein metabolism.

Key Claims

Primary finding · Tentative

early-onset, as well as late-onset, PE affect maternal and neonatal lipid metabolism, potentially contributing to disease manifestation and increased cardiovascular risk later in life

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

delivery-time observational measurements cannot establish causal effects or later cardiovascular consequences

Section 5
Quote verified
Secondary · Supported

In mothers, early- and late-onset PE was associated with atherogenic dyslipidemia, characterized by high plasma triglycerides and low HDL-cholesterol levels.

group comparisons support the association, although residual confounding limits interpretation

Abstract; Section 3.2
Quote verified
Secondary · Tentative

We observed a shift from large HDL to smaller HDL subclasses in early-onset PE, which was associated with an increased plasma antioxidant capacity in mothers.

unadjusted gestational-age differences and an unresolved subgroup correlation limit support for the reported association

Abstract; Sections 3.4, 3.6
Quote verified
Secondary · Tentative

In neonates of early-onset PE, total cholesterol levels were increased, whereas HDL cholesterol efflux capacity was markedly reduced in neonates from late-onset PE.

early-onset cholesterol differences remain confounded by prematurity, while the efflux finding rests on a small exploratory late-onset group

Abstract; Sections 3.2, 3.6
Quote verified
Secondary · Tentative

PE is also associated with changes in neonatal HDL composition and function, demonstrating that complications of pregnancy affect neonatal lipoprotein metabolism.

cross-sectional sampling and early-onset prematurity confounding do not establish an effect of pregnancy complications on neonatal metabolism

Abstract; Section 5
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Paired profiling extends neonatal lipid characterization

Maternal and corresponding cord-blood measurements cover HDL composition, subclasses and functional indices across early- and late-onset preeclampsia. This provides subtype-specific descriptive information beyond the established maternal lipid associations.

↳ Sections 2.1 and 3.2–3.6

#methodological rigour

Specified assays support complementary biochemical measurements

The methods describe apolipoprotein quantification, lipoprotein subclass separation, cholesterol efflux, PON1 activity, antioxidant capacity and LCAT activity. Age and pre-pregnancy BMI matching addresses two measured sources of group difference.

↳ Sections 2.1–2.9

#positioning

Discussion directly engages contrasting prior findings

The discussion compares discordant LDL-subclass, PON1 and neonatal efflux results with earlier studies. It identifies assay differences as a possible explanation for contrasting PON1 findings.

↳ Sections 4.1–4.2

Limitations

#methodological rigour

Prematurity remains inseparable from early-onset comparisons

Early-onset PE is compared with controls at a different gestational age without reported preterm controls or covariate adjustment. Matching on age and BMI does not separate PE-associated lipid differences from maturity-related differences.

↳ Sections 2.1, 2.10, 3.1 and 4.2

#methodological rigour

Causal conclusions exceed delivery-time observational evidence

Blood sampling at delivery does not establish whether lipid differences preceded or followed PE. Statements that PE affects metabolism or led to the HDL subclass shift therefore exceed what the temporal design identifies.

↳ Sections 2.1, 4.2 and 5

#methodological rigour

Antioxidant correlation has unresolved statistical support

Section 3.6 reports rS = 0.301, p = 0.010 for an association described in early-onset PE. If restricted to that group's 18 mothers, a standard approximation gives p approximately 0.225, leaving the analysis population or reported p-value unresolved.

↳ Sections 2.1 and 3.6

Does this match your read? Add your assessment ↓

Nabu Commentary

The paired maternal and cord-blood measurements provide an incremental description of HDL composition and function across PE subtypes. The assay protocols and coherent presentation support interpretation of descriptive differences, particularly the maternal triglyceride and HDL-cholesterol associations. Early-onset comparisons remain entangled with gestational age, and sampling at delivery cannot establish the causal direction asserted in the conclusions. Small groups and broad exploratory testing constrain subtype-specific findings, while the antioxidant correlation requires clarification of its analysis population or reported p-value. The discussion engages conflicting literature but does not fully carry these limitations through to its conclusions.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.8±0.1

Contribution
3.2

Paired maternal and cord-blood profiling across PE subtypes adds descriptive detail on HDL composition, subclasses and function. The advance remains incremental because maternal lipid associations and neonatal efflux changes already have precedents, and the exploratory comparisons do not resolve their causes.

Sections 3.2–3.6 and 4.1–4.2
Methodological Rigour
2.0

Specified biochemical assays and age/BMI matching support descriptive comparisons, but unadjusted gestational-age differences and delivery-time sampling substantially undermine PE-specific causal interpretation. Small groups, broad exploratory testing and the unresolved antioxidant-correlation calculation add analytical uncertainty.

Sections 2.1–2.10, 3.1, 3.6, 4.2 and 5
Reporting
3.6

The results follow a coherent progression from participant characteristics through lipid composition, subclasses and functional measurements. Residual imprecision concerns plasma antioxidant capacity versus HDL-specific function, while the causal overstatement is accounted for in Methodological Rigour.

Sections 3.1–3.7 and 4.1–4.2
Positioning
3.5

The discussion engages supporting and conflicting maternal and neonatal lipid studies, including differences in LDL subclasses, PON1 assays and cholesterol efflux. It acknowledges prematurity and the correlative design but incompletely develops clinical confounders and their consequences for interpretation.

Sections 4.1–4.2

Lower confidence on Contribution, Methodological Rigour — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • We observed a shift from large HDL to smaller HDL subclasses in early-onset PE, which was associated with an increased plasma antioxidant capacity in mothers: "shift in HDL subclass distribution to small HDL particles in maternal early-onset PE (rS = 0.301, p = 0.010)" (Section 3.6) vs "early-onset PE (n = 18) and late-onset PE (n = 14) were recruited" (Section 2.1). Assuming the correlation used the 18 early-onset mothers, a two-sided t approximation for Spearman rho without ties gives p approximately 0.225 rather than 0.010. → Effect on result unclear
Reporting and transparencyClean

Ethics approval with an identifier and written informed consent are declared. No text-grounded reporting or transparency concern was established.

Ethics approval: declared

Reference IntegrityNoted

83 of 85 checkable references verified

85 references in manuscript

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Reproductive health and childbirth · Maternal disorders
Type of advanceEmpirical
Route to useNot stated
AdvanceExtends
BeneficiariesLarge
CitationsFWCI 10.5
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The evidence is a single exploratory cross-sectional observation in one cohort, explicitly correlative and not permitting causal inference.

The discussion and conclusion state only that the findings suggest a contribution to disease manifestation and cardiovascular risk, and call for further studies, naming no real-world use.

Pathway

Researchers and clinicians studying long-term cardiovascular risk could use these lipid and HDL markers to understand and later monitor mothers and offspring affected by preeclampsia.

Barrier

The study is exploratory and correlative with small groups, and the authors themselves state larger cohorts are needed to confirm the results.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia

    Olivia Nonn, Cornelius Fischer, Sabrina Geisberger, et al. · 2021 · Basic medicine

    Primary claim

    Ang IV decreases trophoblastic mitochondrial respiration and increases placental leptin via placental LNPEP.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. Placental physioxia is based on spatial and temporal variations of placental oxygenation throughout pregnancy

    Berthold Huppertz · 2023 · Basic medicine

    Primary claim

    In early-onset preeclampsia cases, all in vivo data available today point to increased oxygen values in the intervillous space of the placenta.

    Tentative
    Evidence Score
    2.4±0.2
    Reliability
    Caveats
  3. Maternal platelets at the first trimester maternal-placental interface - Small players with great impact on placenta development

    Jacqueline Guettler, Désirée Forstner, Martin Gauster · 2021 · Basic medicine

    Primary claim

    In normal early human pregnancy, maternal platelets may contribute to placenta development by acting on both the extravillous- and the villous trophoblast compartment.

    Tentative
    Evidence Score
    3.1±0.1
    Reliability
    Caveats

How the rubric works →